USD 0.01
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 34.29 Million USD | -12.34% |
2022 | 39.11 Million USD | -12.53% |
2021 | 44.72 Million USD | 504.88% |
2020 | 7.39 Million USD | -53.65% |
2019 | 15.95 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 35.2 Million USD | -0.68% |
2024 Q1 | 35.44 Million USD | 3.35% |
2023 Q1 | 37.23 Million USD | -4.81% |
2023 FY | 34.29 Million USD | -12.34% |
2023 Q4 | 34.29 Million USD | -5.03% |
2023 Q3 | 36.1 Million USD | -0.0% |
2023 Q2 | 36.11 Million USD | -3.02% |
2022 Q2 | 76.93 Million USD | -22.51% |
2022 FY | 39.11 Million USD | -12.53% |
2022 Q1 | 99.28 Million USD | 121.98% |
2022 Q4 | 39.11 Million USD | 2.34% |
2022 Q3 | 38.22 Million USD | -50.32% |
2021 Q1 | 4.79 Million USD | -35.15% |
2021 FY | 44.72 Million USD | 504.88% |
2021 Q4 | 44.72 Million USD | 3.69% |
2021 Q3 | 43.13 Million USD | 696.11% |
2021 Q2 | 5.41 Million USD | 12.99% |
2020 Q4 | 7.39 Million USD | 4588.59% |
2020 Q3 | 157.7 Thousand USD | 9.2% |
2020 FY | 7.39 Million USD | -53.65% |
2020 Q2 | 144.42 Thousand USD | -33.54% |
2020 Q1 | 217.3 Thousand USD | 0.0% |
2019 FY | 15.95 Million USD | 0.0% |
2019 Q4 | - USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
CannBioRx Life Sciences Corp. | 5.38 Million USD | -536.563% |
BIMI International Medical Inc. | 30.49 Million USD | -12.446% |
China Jo-Jo Drugstores, Inc. | 80.76 Million USD | 57.539% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 241.75 Million USD | 85.815% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 241.75 Million USD | 85.815% |
Leafly Holdings, Inc. | 34.29 Million USD | 0.0% |
LifeMD, Inc. | 52.91 Million USD | 35.192% |
LifeMD, Inc. | 52.91 Million USD | 35.192% |
TRxADE HEALTH, Inc. | 11.99 Million USD | -186.0% |
PetMed Express, Inc. | 78.36 Million USD | 56.238% |
Walgreens Boots Alliance, Inc. | 68.85 Billion USD | 99.95% |